Home NCDEX Emcure Pharma IPO lists at 31% premium on NSE NCDEX Emcure Pharma IPO lists at 31% premium on NSE By - July 10, 2024 20 0 FacebookTwitterPinterestWhatsApp Emcure IPO opened on July 3 and closed on July 5. It is a book-built issue valued at ₹1,952.03 crores. RELATED ARTICLESMORE FROM AUTHOR NCDEX Latest Business News, Live Updates Today July 21, 2024 NCDEX Lighter bags, heavier hearts: Home, restaurant kitchens feel pinch of vegetable price rise NCDEX Economic Survey to be tabled in Parliament today ahead of Budget: 10 points LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. - Advertisement - APPLICATIONS Daily brief: Ex-WHO scientist on Covid mutation overcoming vaccine immunity, and all the latest... - February 28, 2023 ‘Seems possessed’: Uddhav hits out at Bommai on Maha-Karnataka border dispute - November 25, 2022 CM Mohan Yadav exacting revenge on Shivraj Chouhan: Congress’s Jitu Patwari - January 6, 2024 Singer Anup Jalota says India should be Hindu Rashtra: ‘Like in Kashmir…’ - February 15, 2023 HOT NEWS Uttar Pradesh govt cancels all doctors’ leaves as Dengue cases rise - October 19, 2022 0 News Uttar Pradesh govt cancels all doctors' leaves as Dengue cases rise Between January and September this year, the state reported 2,103 dengue cases.